RETRACTION: CCDC7 Activates Interleukin-6 and Vascular Endothelial Growth Factor to Promote Proliferation via the JAK-STAT3 Pathway in Cervical Cancer Cells (Retraction of Vol 13, Pg 6229, 2020)

被引：0
|
作者：
Zhou, C.
He, X.
Zeng, Q.
Zhang, P.
Wang, C.
机构：
来源：
ONCOTARGETS AND THERAPY | 2023年 / 16卷
关键词：
D O I：
10.2147/OTT.S424822
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：407 / 407
页数：1
相关论文
共 22 条
  • [1] RETRACTED: CCDC7 Activates Interleukin-6 and Vascular EndothelialGrowth Factor to Promote Proliferation via the JAK-STAT3 Pathway in Cervical Cancer Cells (Retracted article. See vol. 16, pg. 407, 2023)
    Zhou, Cong
    He, Xiang
    Zeng, Qi
    Zhang, Peng
    Wang, Chunting
    ONCOTARGETS AND THERAPY, 2020, 13 : 6229 - 6244
  • [2] RETRACTION: MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling Pathway (Retraction of Vol 33, Pg 103, 2018)
    Dai, Hong
    Wang, Chunmei
    Yu, Zhihai
    He, Donglin
    Yu, Kun
    Liu, Yin
    Wang, Sheng
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2021, 36 (06) : 535 - 535
  • [3] RETRACTION: Lamin B1 Overexpresses in Lung Adenocarcinoma and Promotes Proliferation in Lung Cancer Cells via AKT Pathway (Retraction of Vol 13, Pg 3129, 2020)
    Li, W.
    Li, X.
    Li, X.
    ONCOTARGETS AND THERAPY, 2023, 16 : 747 - 747
  • [4] RETRACTION: Cinobufagin Suppresses the Characteristics of Osteosarcoma Cancer Cells by Inhibiting the IL-6-OPN-STAT3 Pathway (Retraction of Vol 13, Pg 4075, 2019)
    Zhang, C.
    Ma, K.
    Li, W. Y.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 4445 - 4445
  • [5] RETRACTION: MicroRNA-143 suppresses the proliferation and metastasis of human gastric cancer cells via modulation of STAT3 expression (Retraction of Vol 12, Pg 867, 2020)
    Wu, Y. Y.
    Wan, X. Y.
    Zhao, X.
    Song, Z. Y.
    Xu, Z. H.
    Tao, Y. M.
    Sun, C. X.
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (04): : 3913 - 3913
  • [6] RETRACTION: IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells (Retraction of Vol 13, Pg 9721, 2020)
    Li, Y.
    Chen, G.
    Han, Z.
    Cheng, H.
    Qiao, L.
    Li, Y.
    ONCOTARGETS AND THERAPY, 2022, 15 : 871 - 871
  • [7] Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells
    Huang, Yu-Han
    Yang, Hung-Yu
    Huang, Shiu-Wen
    Ou, George
    Hsu, Ya-Fen
    Hsu, Ming-Jen
    PLOS ONE, 2016, 11 (07):
  • [8] Interleukin-6 trans-signalling induces vascular endothelial growth factor synthesis partly via Janus kinases-STAT3 pathway in human mesothelial cells
    Yang, Xiaoxiao
    Lin, Aiwu
    Jiang, Na
    Yan, Hao
    Ni, Zhaohui
    Qian, Jiaqi
    Fang, Wei
    NEPHROLOGY, 2017, 22 (02) : 150 - 158
  • [9] RETRACTION: LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway (Retraction of Vol 107, Pg 270, 2018)
    Zhang, Butian
    Yu, Lili
    Han, Ning
    Hu, Zhenzhen
    Wang, Shuang
    Ding, Lei
    Jiang, Jinlan
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 173
  • [10] RETRACTION: LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway (Retraction of Vol 111, Pg 1508, 2019)
    Zhang, Butian
    Yu, Lili
    Han, Ning
    Hu, Zhenzhen
    Wang, Shuang
    Ding, Lei
    Jiang, Jinlan
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 173
123